Cargando…
USE OF FDA-APPROVED ALZHEIMER’S DISEASE MEDICATIONS AMONG NON-INSTITUTIONALIZED U.S. ADULTS AGE 60 YEARS AND OLDER
This study examined the use of Alzheimer’s Disease medications (ADMs) among non-institutionalized U.S. adults aged 60 years and older. It described the characteristics of ADM users, compared them to adults who were not currently using ADMs, and examined how demographic characteristics, living arrang...
Autores principales: | Frenk, Steven, Sautter, Jessica M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6840710/ http://dx.doi.org/10.1093/geroni/igz038.1737 |
Ejemplares similares
-
LIFESTYLE BEHAVIORS AND RACIAL DIFFERENCES IN ALZHEIMER’S DISEASE RISK
por: Wong, Roger
Publicado: (2019) -
THE EPIDEMIOLOGY OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS AMONG ARAB AMERICANS
por: Dallo, Florence, et al.
Publicado: (2019) -
FOSTERING COMPASSIONATE CARE FOR PERSONS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
por: Cotton, Samantha G, et al.
Publicado: (2019) -
PREDICTORS OF DEMENTIA IN OLDER ADULTS: VARIATION BY NATIVITY STATUS AND RACE-ETHNICITY
por: Moon, Heehyul, et al.
Publicado: (2019) -
MILD BEHAVIORAL IMPAIRMENT AS A PREDICTOR OF COGNITIVE FUNCTIONING IN OLDER ADULTS
por: Rouse, Hillary J, et al.
Publicado: (2019)